Akzo Nobels Pharma
proactive on growthPressi.com - 06 Nov 2002... Total worldwide sales of antidepressant Remeron® are
up 20% year to date; lawsuits
in the United States regarding Organons patent
for use of Remeron in ...
Israel's
Teva sees stronger 4th quarter, major drug approval
Globes Online, Israel - 29 Oct
2002
... is waiting for US Food and Drug
Administration approval to market its generic versions
of GlaxoSmithKline
PLC's Augmentin antibiotic and Organon's Remeron anti ...
Job
cuts fuel fears at Akzo Nobel drugs unit
Financial Times (subscription), UK - 23 Oct
2002
... more than half of group operating
income, had already suffered set-backs over delayed
product launches and
competition fears, particularly related to Remeron ...
Akzo
Q3 net seen edging higher thanks to coatings
Forbes - 21 Oct 2002
... its anti-thrombosis drug Arixtra and another expected weak
quarter in contraceptives,
the pressure will remain on its current champion
anti-depressant Remeron ...
